As part of its evolving education offering, FIGO is delighted to launch its first capacity strengthening online course: ...

We are proud to announce the recipients of the 2025 FIGO and Chien-Tien Hsu Fellowship in Gynaecologic Oncology: Dr Pedro H.

Anaemia is an under-recognised and undertreated chronic state that adversely impacts more than 2 billion people worldwide, predominantly women, the fetus and children. 1 Iron deficiency is the most ...

FIGO regularly issues statements and joint statements.Adolescence and Youth Health Adolescent Health Menopausal Age Reproductive Age Breast Health FIGO World Congress FIGO Regional Congress FIGO CPD ...

FIGO regards reproductive choice, including access to safe abortion services, as a basic and non-negotiable tool for ensuring the human rights of every woman, not just in one region or country, but ...

Joint statement of recommendation for the use of uterotonics for the prevention of postpartum haemorrhage ...

The situation in Gaza, Israel and the surrounding region exposes women, children, newborns and other vulnerable people to extreme risk, including social, gender and reproductive injustices. At the ...

FIGO’s 2024-2025 free webinar series tackles the most pressing issues on women’s health and rights.Organised by FIGO’s Divisions and Committees, FIGO’s webinar series brings together women’s health ...

The 2021 edition of the FIGO Cancer Report contains updates on the management of gynaecological cancers combined with pertinent papers on gynaecological oncology, which we hope the reader will find ...

Women’s health is underserved, understudied and often underresourced in innovations with disproportionately low research and development funding relative to the burden of morbidity and mortality and ...

Up to 500 million women and girls are living each month in period poverty. Due to financial constraints, they lack access to essential tools for menstrual hygiene management (MHM), such as sanitary ...

The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).